Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in micein vivo-Reference-Cited by-同舟云学术

Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in micein vivo

Published:2011-06-27 Issue:6 Volume:163 Page:1250-1262
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Ueng Yune-Fang,Chen Chien-Chih,Chung Yu-Ting,Liu Tsung-Yun,Chang Yu-Ping,Lo Wei-Sheng,Murayama Norie,Yamazaki Hiroshi,Souček Pavel,Chau Gar-Yang,Chi Chin-Wen,Chen Ruei-Ming,Li Ding-Tzai

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.2011.01341.x/fullpdf

Reference46 articles.

1. Two substrate kinetics of drug-metabolizing enzyme system of hepatic microsomes;Alvares;Mol Pharmacol,1970

2. Allelochemicals from Stauranthus perforatus, a Rutaceous tree of Yucatan Peninsula, Mexico;Anaya;Phytochem,2005

3. Psoralen photochemotherapy of cutaneous disorders;Anderson;Ann Rev Pharmacol Toxicol,1980

4. A novel single nucleotide polymorphism altering stability and activity of CYP2A6;Ariyoshi;Biochem Biophys Res Comm,2001

5. LC-MS/MS for the detection of DNA interstrand cross-links formed by 8-methoxypsoralen and UVA irradiation in human cells;Cao;Anal Chem,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Review of Naturally Derived Substances That Act as Inhibitors of the Nicotine Metabolizing Enzyme Cytochrome P450 2A6;International Journal of Molecular Sciences;2024-07-23

2. Oxypeucedanin is a Mechanism-based Inactivator of CYP2B6 and CYP2D6;Current Drug Metabolism;2021-09

3. Chalepin and Chalepensin: Occurrence, Biosynthesis and Therapeutic Potential;Molecules;2021-03-14

4. Inhibition of human cytochrome P450 2A6 by 7-hydroxycoumarin analogues: Analysis of the structure-activity relationship and isoform selectivity;European Journal of Pharmaceutical Sciences;2019-08

5. Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy;Basic & Clinical Pharmacology & Toxicology;2018-07-19